Covaxin Failed To Secure Emergency Use Authorisation In US
The emergency use authorisation of Bharat Biotech COVID-19 vaccine 'Covaxin' has been rejected by the US drug regulator. The company will now submit only a biologics license application for 'Covaxin'. Meanwhile, Bharat Biotech has decided to publish its phase-3 clinical trial data in July. Notably, 'Covaxin' has secured an approval in India and is one of those COVID vaccines which are being administered to people.